1 Pneumococcal Vaccine Polyvalent Market Overview 1.1 Product Overview and Scope of Pneumococcal Vaccine Polyvalent 1.2 Pneumococcal Vaccine Polyvalent Segment by Type 1.2.1 Global Pneumococcal Vaccine Polyvalent Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Prevnar 13 1.2.3 Pneumovax23 1.3 Pneumococcal Vaccine Polyvalent Segment by Application 1.3.1 Global Pneumococcal Vaccine Polyvalent Sales Comparison by Application: (2021-2027) 1.3.2 18 Years and Younger 1.3.3 19 To 64 Years Old 1.3.4 65 Years and Older 1.4 Global Pneumococcal Vaccine Polyvalent Market Size Estimates and Forecasts 1.4.1 Global Pneumococcal Vaccine Polyvalent Revenue 2016-2027 1.4.2 Global Pneumococcal Vaccine Polyvalent Sales 2016-2027 1.4.3 Pneumococcal Vaccine Polyvalent Market Size by Region: 2016 Versus 2021 Versus 2027 2 Pneumococcal Vaccine Polyvalent Market Competition by Manufacturers 2.1 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturers (2016-2021) 2.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Pneumococcal Vaccine Polyvalent Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Pneumococcal Vaccine Polyvalent Manufacturing Sites, Area Served, Product Type 2.5 Pneumococcal Vaccine Polyvalent Market Competitive Situation and Trends 2.5.1 Pneumococcal Vaccine Polyvalent Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Pneumococcal Vaccine Polyvalent Players Market Share by Revenue 2.5.3 Global Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Pneumococcal Vaccine Polyvalent Retrospective Market Scenario by Region 3.1 Global Pneumococcal Vaccine Polyvalent Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Pneumococcal Vaccine Polyvalent Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country 3.3.1 North America Pneumococcal Vaccine Polyvalent Sales by Country 3.3.2 North America Pneumococcal Vaccine Polyvalent Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country 3.4.1 Europe Pneumococcal Vaccine Polyvalent Sales by Country 3.4.2 Europe Pneumococcal Vaccine Polyvalent Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Pneumococcal Vaccine Polyvalent Market Facts & Figures by Region 3.5.1 Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region 3.5.2 Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country 3.6.1 Latin America Pneumococcal Vaccine Polyvalent Sales by Country 3.6.2 Latin America Pneumococcal Vaccine Polyvalent Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country 3.7.1 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country 3.7.2 Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Pneumococcal Vaccine Polyvalent Historic Market Analysis by Type 4.1 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2016-2021) 4.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2016-2021) 4.3 Global Pneumococcal Vaccine Polyvalent Price by Type (2016-2021) 5 Global Pneumococcal Vaccine Polyvalent Historic Market Analysis by Application 5.1 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2016-2021) 5.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2016-2021) 5.3 Global Pneumococcal Vaccine Polyvalent Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Merck & Co. 6.1.1 Merck & Co. Corporation Information 6.1.2 Merck & Co. Description and Business Overview 6.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Merck & Co. Pneumococcal Vaccine Polyvalent Product Portfolio 6.1.5 Merck & Co. Recent Developments/Updates 6.2 Pfizer 6.2.1 Pfizer Corporation Information 6.2.2 Pfizer Description and Business Overview 6.2.3 Pfizer Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Pfizer Pneumococcal Vaccine Polyvalent Product Portfolio 6.2.5 Pfizer Recent Developments/Updates 7 Pneumococcal Vaccine Polyvalent Manufacturing Cost Analysis 7.1 Pneumococcal Vaccine Polyvalent Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Pneumococcal Vaccine Polyvalent 7.4 Pneumococcal Vaccine Polyvalent Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Pneumococcal Vaccine Polyvalent Distributors List 8.3 Pneumococcal Vaccine Polyvalent Customers 9 Pneumococcal Vaccine Polyvalent Market Dynamics 9.1 Pneumococcal Vaccine Polyvalent Industry Trends 9.2 Pneumococcal Vaccine Polyvalent Growth Drivers 9.3 Pneumococcal Vaccine Polyvalent Market Challenges 9.4 Pneumococcal Vaccine Polyvalent Market Restraints 10 Global Market Forecast 10.1 Pneumococcal Vaccine Polyvalent Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Pneumococcal Vaccine Polyvalent by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Pneumococcal Vaccine Polyvalent by Type (2022-2027) 10.2 Pneumococcal Vaccine Polyvalent Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Pneumococcal Vaccine Polyvalent by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Pneumococcal Vaccine Polyvalent by Application (2022-2027) 10.3 Pneumococcal Vaccine Polyvalent Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Pneumococcal Vaccine Polyvalent by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Pneumococcal Vaccine Polyvalent by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Pneumococcal Vaccine Polyvalent Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Pneumococcal Vaccine Polyvalent Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Pneumococcal Vaccine Polyvalent Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Pneumococcal Vaccine Polyvalent Covered in This Study Table 5. Global Pneumococcal Vaccine Polyvalent Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturers (2016-2021) Table 7. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Pneumococcal Vaccine Polyvalent Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Pneumococcal Vaccine Polyvalent Manufacturing Sites and Area Served Table 11. Manufacturers Pneumococcal Vaccine Polyvalent Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Pneumococcal Vaccine Polyvalent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccine Polyvalent as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Pneumococcal Vaccine Polyvalent Sales by Region (2016-2021) & (K Units) Table 16. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2016-2021) Table 17. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Pneumococcal Vaccine Polyvalent Sales by Country (2016-2021) & (K Units) Table 19. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2016-2021) Table 20. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2016-2021) Table 22. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2016-2021) & (K Units) Table 23. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2016-2021) Table 24. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2016-2021) Table 30. Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2016-2021) & (K Units) Table 31. Latin America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2016-2021) Table 32. Latin America Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2016-2021) Table 38. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Type (2016-2021) Table 39. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2016-2021) Table 40. Global Pneumococcal Vaccine Polyvalent Revenue (Million US$) by Type (2016-2021) Table 41. Global Pneumococcal Vaccine Polyvalent Revenue Share by Type (2016-2021) Table 42. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Type (2016-2021) Table 43. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Application (2016-2021) Table 44. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2016-2021) Table 45. Global Pneumococcal Vaccine Polyvalent Revenue (Million US$) by Application (2016-2021) Table 46. Global Pneumococcal Vaccine Polyvalent Revenue Share by Application (2016-2021) Table 47. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Application (2016-2021) Table 48. Merck & Co. Corporation Information Table 49. Merck & Co. Description and Business Overview Table 50. Merck & Co. Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Merck & Co. Pneumococcal Vaccine Polyvalent Product Table 52. Merck & Co. Recent Developments/Updates Table 53. Pfizer Corporation Information Table 54. Pfizer Description and Business Overview Table 55. Pfizer Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Pfizer Pneumococcal Vaccine Polyvalent Product Table 57. Pfizer Recent Developments/Updates Table 58. Production Base and Market Concentration Rate of Raw Material Table 59. Key Suppliers of Raw Materials Table 60. Pneumococcal Vaccine Polyvalent Distributors List Table 61. Pneumococcal Vaccine Polyvalent Customers List Table 62. Pneumococcal Vaccine Polyvalent Market Trends Table 63. Pneumococcal Vaccine Polyvalent Growth Drivers Table 64. Pneumococcal Vaccine Polyvalent Market Challenges Table 65. Pneumococcal Vaccine Polyvalent Market Restraints Table 66. Global Pneumococcal Vaccine Polyvalent Sales Forecast by Type (2022-2027) & (K Units) Table 67. Global Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Type (2022-2027) Table 68. Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Type (2022-2027) & (US$ Million) Table 69. Global Pneumococcal Vaccine Polyvalent Revenue Market Share Forecast by Type (2022-2027) Table 70. Global Pneumococcal Vaccine Polyvalent Sales Forecast by Application (2022-2027) & (K Units) Table 71. Global Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Application (2022-2027) Table 72. Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Application (2022-2027) & (US$ Million) Table 73. Global Pneumococcal Vaccine Polyvalent Revenue Market Share Forecast by Application (2022-2027) Table 74. Global Pneumococcal Vaccine Polyvalent Sales Forecast by Region (2022-2027) & (K Units) Table 75. Global Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Region (2022-2027) Table 76. Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Region (2022-2027) & (US$ Million) Table 77. Global Pneumococcal Vaccine Polyvalent Revenue Market Share Forecast by Region (2022-2027) Table 78. Research Programs/Design for This Report Table 79. Key Data Information from Secondary Sources Table 80. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Pneumococcal Vaccine Polyvalent Figure 2. Global Pneumococcal Vaccine Polyvalent Market Share by Type in 2020 & 2027 Figure 3. Prevnar 13 Product Picture Figure 4. Pneumovax23 Product Picture Figure 5. Global Pneumococcal Vaccine Polyvalent Market Share by Application in 2020 & 2027 Figure 6. 18 Years and Younger Figure 7. 19 To 64 Years Old Figure 8. 65 Years and Older Figure 9. Global Pneumococcal Vaccine Polyvalent Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Pneumococcal Vaccine Polyvalent Market Size 2016-2027 (US$ Million) Figure 11. Global Pneumococcal Vaccine Polyvalent Sales 2016-2027 (K Units) Figure 12. Global Pneumococcal Vaccine Polyvalent Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Pneumococcal Vaccine Polyvalent Sales Share by Manufacturers in 2020 Figure 14. Global Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Pneumococcal Vaccine Polyvalent Players: Market Share by Revenue in 2020 Figure 16. Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2016-2021) Figure 18. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region in 2020 Figure 19. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2016-2021) Figure 20. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region in 2020 Figure 21. U.S. Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Pneumococcal Vaccine Polyvalent by Type (2016-2021) Figure 46. Sales Market Share of Pneumococcal Vaccine Polyvalent by Application (2016-2021) Figure 47. Sales Market Share of Pneumococcal Vaccine Polyvalent by Application in 2020 Figure 48. Revenue Share of Pneumococcal Vaccine Polyvalent by Application (2016-2021) Figure 49. Revenue Share of Pneumococcal Vaccine Polyvalent by Application in 2020 Figure 50. Manufacturing Cost Structure of Pneumococcal Vaccine Polyvalent Figure 51. Manufacturing Process Analysis of Pneumococcal Vaccine Polyvalent Figure 52. Pneumococcal Vaccine Polyvalent Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Merck & Co. Pfizer